glp 1 agonist medications How GLP-1 are transforming diabetes and weight loss treatment ascendis pharma glp-1 receptor agonist
Description
The patient experienced full remission of BAD symptoms when treated with liraglutide, but only temporary effect of semaglutide, which only improved BAD symptoms during the 2 postinjection days but had no effect during the following 5 days until the next dose (16)
Novo Nordisk, a competitor to Eli Lilly, has already sought FDA approval for an oral semaglutide pill, its oral GLP-1 pill, and is expected to receive a decision by the end of this year
A few of the key players in the market are Amgen Inc
doi: 10.1007/s11657-022-01061-5 4 BouyerBLeroyFRudantJWeillACosteJ
Prog Neurobiol (2014) 118:118
